Skip to main content
. 2003 Nov;89(11):1363–1372. doi: 10.1136/heart.89.11.1363

Table 3.

Drugs that can prolong QT interval and torsades de pointes (this list is not comprehensive)

Antiarrhythmic drugs Type 1A (TdP reported in all)
Quinidine (TdP reported)
Procainamide (TdP reported)
Disopyramide (TdP reported)
Ajmaline (TdP reported)
Type 1C (increase QT by prolonging QRS interval)
Encainide
Flecainide
Type 3 (TdP reported in all)
Amiodarone
Sotalol
d-Sotalol
Bretylium
Ibutilide
Dofetilide
Amakalant
Semantilide
Calcium channel blockers Prenylamine (TdP reported, withdrawn)
Bepridil (TdP reported, withdrawn)
Terodiline (TdP reported, withdrawn)
Psychiatric drugs Thioridazine (TdP reported)
Chlorpromazine (TdP reported)
Haloperidol (TdP reported)
Droperidol (TdP reported)
Amitriptyline
Nortriptyline
Imipramine (TdP reported)
Desipramine (TdP reported)
Clomipramine
Maprotiline (TdP reported)
Doxepin (TdP reported)
Lithium (TdP reported)
Chloral hydrate
Sertindole (TdP reported, withdrawn in the UK)
Pimozide (TdP reported)
Ziprasidone
Antihistamines Terfenadine (TdP reported, withdrawn in the USA)
Astemizole (TdP reported)
Diphenhydramine (TdP reported)
Hydroxyzine
Ebastine
Loratadine
Mizolastine
Antimicrobial and antimalarial drugs Erythromycin (TdP reported)
Clarithromycin (TdP reported)
Ketoconazole
Pentamidine (TdP reported)
Quinine
Chloroquine (TdP reported)
Halofantrine (TdP reported)
Amantadine (TdP reported)
Sparfloxacin
Grepafloxacin (TdP reported, withdrawn in the UK and USA)
Pentavalent antimonial meglumine
Serotonin agonists/antagonists Ketanserin (TdP reported)
Cisapride (TdP reported, withdrawn in the UK and USA)
Immunosuppressant Tacrolimus (TdP reported)
Antidiuretic hormone Vasopressin (TdP reported)
Other agents Adenosine
Organophosphates
Probucol (TdP reported)
Papaverine (TdP reported)
Cocaine